Physician profile
Bramdeo Singh
NPI 1093743999
$1,940.22
in general payments reported to CMS, 2019-2025
10 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $138 · 2021: $506 · 2022: $600 · 2023: $261 · 2024: $198 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,134.59 | 2020-2024 | Xarelto |
| Optinose US, INC. | $248.82 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $164.95 | 2019-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $132.47 | 2019-2021 | |
| Gilead Sciences, INC. | $119.37 | 2022-2025 | Veklury |
| Janssen Biotech, INC. | $56.11 | 2019 | |
| Medtronic, INC. | $30.29 | 2025 | Kyphon Express II Kyphopak Tray |
| Viatris Specialty LLC | $26.83 | 2025 | Yupelri |
| Fisher & Paykel Healthcare INC | $14.92 | 2022 | |
| Pfizer INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bramdeo Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.